Lack of effect of benralizumab on signs and symptoms of moderate-to-severe atopic dermatitis: Results from the phase 2 randomized, double-blind, placebo-controlled HILLIER trial

被引：7
|
作者：
Guttman-Yassky, E. [1 ,9 ]
Bahadori, L. [2 ]
Brooks, L. [3 ]
Clark, K. L. [3 ]
Grindebacke, H. [4 ]
Ho, C. N. [5 ]
Katial, R. [6 ,7 ]
Pham, T. -H. [8 ]
Walton, C. [3 ]
Datto, C. J. [2 ]
机构：
[1] Icahn Sch Med Mt Sinai, New York, NY USA
[2] AstraZeneca, Late Stage Dev Resp & Immunol, BioPharmaceut R&D, Gaithersburg, MD USA
[3] AstraZeneca, Late Stage Dev Resp & Immunol, BioPharmaceut R&D, Cambridge, England
[4] AstraZeneca, Late Stage Dev Resp & Immunol, BioPharmaceut R&D, Gothenburg, Sweden
[5] AstraZeneca, Patient Ctr Sci, BioPharmaceut Med, Gaithersburg, MD USA
[6] AstraZeneca, BioPharmaceut Med, Gaithersburg, MD USA
[7] Natl Jewish Hlth, Denver, CO USA
[8] AstraZeneca, Translat Sci & Expt Med, Early Resp & Immunol, BioPharmaceut R&D, Gaithersburg, MD USA
[9] Icahn Sch Med Mt Sinai, Kimberly & Er J Waldman Dept Dermatol, 1425 Madison Ave,Box 1047, New York, NY 10029 USA
来源：
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY | 2023年 / 37卷 / 10期
关键词：
EFFICACY; SAFETY;
D O I：
10.1111/jdv.19195
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：E1211 / E1214
页数：4
相关论文
共 50 条
  • [41] Dupilumab treatment in patients with atopic hand and foot dermatitis: results from a phase 3, randomized, double-blind, placebo-controlled trial
    Simpson, Eric L.
    Silverberg, Jonathan, I
    Worm, Margitta
    Honari, Golara
    Masuda, Koji
    Sygula, Ewa
    Maloney, Jennifer
    Mannent, Leda P.
    Xiao, Jing
    Dubost-Brama, Ariane
    Bansal, Ashish
    BRITISH JOURNAL OF DERMATOLOGY, 2023, 188
  • [42] Dupilumab treatment in patients with atopic hand and foot dermatitis: Results from a phase 3, randomized, double-blind, placebo-controlled trial
    Simpson, E.
    Silverberg, J.
    Worm, M.
    Honari, G.
    Masuda, K.
    Sygula, E.
    Maloney, J.
    Mannent, L.
    Xiao, J.
    Dubost-Brama, A.
    Bansal, A.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2023, 143 (11) : S350 - S350
  • [43] Upadacitinib improved patient-reported pruritus in moderate-to-severe atopic dermatitis: results from a phase 2B randomized, placebo-controlled trial
    Hong, C. -H.
    Wu, T.
    Calimlim, B.
    Teixeira, H.
    de Bruin-Weller, M.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2019, 33 : 10 - 10
  • [44] Benralizumab effect on severe chronic rhinosinusitis with nasal polyps (CRSwNP): A randomized double-blind placebo-controlled trial
    Tversky, Jody
    Lane, Andrew P.
    Azar, Antoine
    CLINICAL AND EXPERIMENTAL ALLERGY, 2021, 51 (06): : 836 - 844
  • [45] Efficacy and safety of vunakizumab in moderate-to-severe chronic plaque psoriasis: A randomized, double-blind, placebo-controlled phase 3 trial
    Yan, Kexiang
    Li, Fuqiu
    Bi, Xiaodong
    Han, Ling
    Zhang, Zhenghua
    Chen, Rixin
    Li, Yuye
    Zhang, Litao
    Wang, Xiaohua
    Li, Linfeng
    Lu, Jianyun
    Xu, Ai'e
    Yang, Sen
    Lu, Yan
    Sun, Jianfang
    Li, Zhiming
    Zhu, Xiaohong
    Jiang, Meiying
    Zhang, Siping
    Wang, Wenqing
    Li, Yanling
    Meng, Zudong
    Li, Hongyi
    Mou, Kuanhou
    Han, Xiuping
    Li, Shanshan
    Chen, Aijun
    Li, Xin
    Liu, Donghua
    Zhang, Chunlei
    Ji, Chao
    Wang, Yu
    Cheng, Hao
    Cui, Xiaojing
    Yao, Xiaoyan
    Bai, Xiaoyan
    Dong, Guangchao
    Xu, Jinhua
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2025, 92 (01) : 92 - 99
  • [46] A Randomized, Double-Blind, Placebo-Controlled Phase 2 Study of Brodalumab in Patients With Moderate-to-Severe Crohn's Disease
    Targan, Stephan R.
    Feagan, Brian
    Vermeire, Severine
    Panaccione, Remo
    Melmed, Gil Y.
    Landers, Carol
    Li, Dalin
    Russell, Chris
    Newmark, Richard
    Zhang, Nan
    Chon, Yun
    Hsu, Yi-Hsiang
    Lin, Shao-Lee
    Klekotka, Paul
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2016, 111 (11): : 1599 - 1607
  • [47] Effect of memantine combination therapy on symptoms in patients with moderate-to-severe depressive disorder: randomized, double-blind, placebo-controlled study
    Amidfar, M.
    Khiabany, M.
    Kohi, A.
    Salardini, E.
    Arbabi, M.
    Azizi, M. Roohi
    Zarrindast, M. -R.
    Mohammadinejad, P.
    Zeinoddini, A.
    Akhondzadeh, S.
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2017, 42 (01) : 44 - 50
  • [48] Safety and efficacy of upadacitinib in combination with topical corticosteroids in adolescents and adults with moderate-to-severe atopic dermatitis (AD Up): results from a randomised, double-blind, placebo-controlled, phase 3 trial
    Reich, Kristian
    Teixeira, Henrique D.
    de Bruin-Weller, Marjolein
    Bieber, Thomas
    Soong, Weily
    Kabashima, Kenji
    Werfel, Thomas
    Zeng, Jiewei
    Huang, Xiaohong
    Hu, Xiaofei
    Hendrickson, Barbara A.
    Ladizinski, Barry
    Chu, Alvina D.
    Silverberg, Jonathan I.
    LANCET, 2021, 397 (10290): : 2169 - 2181
  • [49] Pioglitazone Adjunctive Therapy for Moderate-to-Severe Major Depressive Disorder: Randomized Double-Blind Placebo-Controlled Trial
    Khatereh Sepanjnia
    Amirhossein Modabbernia
    Mandana Ashrafi
    Mohammad-Jafar Modabbernia
    Shahin Akhondzadeh
    Neuropsychopharmacology, 2012, 37 : 2093 - 2100
  • [50] Cyclosporine for moderate-to-severe alopecia areata: A double-blind, randomized, placebo-controlled clinical trial of efficacy and safety
    Lai, Vivien Wai Yun
    Chen, Gang
    Gin, Douglas
    Sinclair, Rodney
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2019, 81 (03) : 694 - 701
12345